Cargando…

Infection control management and surveillance of carbapenem-resistant Gram-negative bacteria in hematopoietic stem cell recipients

Hematopoietic stem cell transplantation (HSCT) is a curative treatment option for selected diseases of the hematopoietic system. In the context of HSCT, bloodstream infections caused by Gram-negative bacteria (GNB) significantly contribute to morbidity and mortality. Antibiotic treatment of bloodstr...

Descripción completa

Detalles Bibliográficos
Autores principales:	Baier, Claas, Beck, Maleen, Panagiota, Viktoria, Lueck, Catherina, Kharazipour, Daniel, Hintze, Sophie Charlotte, Bollin, Robin, Ebadi, Ella, Ziesing, Stefan, Eder, Matthias, Bange, Franz-Christoph, Beutel, Gernot
Formato:	Online Artículo Texto
Lenguaje:	English
Publicado:	BioMed Central 2019
Materias:	Short Report
Acceso en línea:	https://www.ncbi.nlm.nih.gov/pmc/articles/PMC6805597/ https://www.ncbi.nlm.nih.gov/pubmed/31649817 http://dx.doi.org/10.1186/s13756-019-0606-3

Ejemplares similares

Epidemiology and infection control of carbapenem resistant Acinetobacter baumannii and Klebsiella pneumoniae at a German university hospital: a retrospective study of 5 years (2015–2019)
por: Chhatwal, Patrick, et al.
Publicado: (2021)

Impact of chronic graft-versus-host-disease on intensive care outcome in allogeneic hematopoietic stem cell recipients
por: Lueck, Catherina, et al.
Publicado: (2022)

Epidemiologic and Molecular Investigation of a MRSA Outbreak Caused by a Contaminated Bathtub for Carbon Dioxide Hydrotherapy and Review of the Literature
por: Baier, Claas, et al.
Publicado: (2020)

Epidemiology, antimicrobial resistance, and mortality risk factors of carbapenem resistant gram-negative bacteria in hematopoietic stem cell transplantation recipients
por: Jia, Yan, et al.
Publicado: (2023)

Influenza and respiratory syncytial virus screening for the detection of asymptomatically infected patients in hematology and oncology
por: Baier, Claas, et al.
Publicado: (2018)

Detection of Serratia marcescens in neonatal intensive care units requires a rapid and comprehensive infection control response starting with the very first case
por: Böhne, Carolin, et al.
Publicado: (2021)

Incidence, risk factors and healthcare costs of central line-associated nosocomial bloodstream infections in hematologic and oncologic patients
por: Baier, Claas, et al.
Publicado: (2020)

Clinical course, treatment and outcome of Pneumocystis pneumonia in immunocompromised adults: a retrospective analysis over 17 years
por: Schmidt, Julius J., et al.
Publicado: (2018)

Compliance with hand disinfection in the surgical area of an orthopedic university clinic: results of an observational study
por: Baier, Claas, et al.
Publicado: (2022)

Incidence of Carbapenem-Resistant Gram Negatives in Italian Transplant Recipients: A Nationwide Surveillance Study
por: Lanini, Simone, et al.
Publicado: (2015)

Target capture sequencing reveals a monoclonal outbreak of respiratory syncytial virus B infections among adult hematologic patients
por: Baier, Claas, et al.
Publicado: (2022)

Epidemiology and infection control of Methicillin-resistant Staphylococcus aureus in a German tertiary neonatal intensive and intermediate care unit: A retrospective study (2013–2020)
por: Böhne, Carolin, et al.
Publicado: (2022)

Molecular characteristics and successful management of a respiratory syncytial virus outbreak among pediatric patients with hemato-oncological disease
por: Baier, Claas, et al.
Publicado: (2018)

Drug Resistance and Risk Factors for Acquisition of Gram-Negative Bacteria and Carbapenem-Resistant Organisms Among Liver Transplant Recipients
por: Wu, Xiaoxia, et al.
Publicado: (2022)

Comparison of Risk Factors and Outcomes in Carbapenem-Resistant and Carbapenem-Susceptible Gram-Negative Bacteremia
por: Cetin, Sinan, et al.
Publicado: (2021)

Effectiveness of a double-carbapenem combinations against carbapenem-resistant Gram-negative bacteria
por: Lu, Jiayue, et al.
Publicado: (2022)

450 Multidrug Resistant Gram Negative Bacteria in a Cohort of Hematopoietic Stem Cell Transplant Recipients
por: Larue, Richard, et al.
Publicado: (2014)

Epidemiology and Diagnostics of Carbapenem Resistance in Gram-negative Bacteria
por: Nordmann, Patrice, et al.
Publicado: (2019)

Global Threat of Carbapenem-Resistant Gram-Negative Bacteria
por: Jean, Shio-Shin, et al.
Publicado: (2022)

Single-Dose Pharmacokinetics and Total Removal of Cyclophosphamide in a Patient with Acute Kidney Injury Undergoing Intermittent Haemodialysis and Prolonged Intermittent Kidney Replacement Therapy: A Case Report
por: Lück, Catherina, et al.
Publicado: (2023)

Navigating preemptive and therapeutic donor lymphocyte infusions in advanced myeloid malignancies by high-sensitivity chimerism analysis
por: Stadler, Michael, et al.
Publicado: (2022)

The Resistance Mechanism Governs Physiological Adaptation of Escherichia coli to Growth With Sublethal Concentrations of Carbapenem
por: Schäfer, Franca, et al.
Publicado: (2022)

The role of carbapenems in initial therapy for serious Gram-negative infections
por: Rahal, James J
Publicado: (2008)

Optimizing the use of carbapenems in the face of increasing Gram-negative resistance
por: Ramphal, Reuben
Publicado: (2008)

Therapy of Infections due to Carbapenem-Resistant Gram-Negative Pathogens
por: Lee, Chang-Seop, et al.
Publicado: (2014)

Treatment Options for Carbapenem-resistant Gram-negative Bacterial Infections
por: Doi, Yohei
Publicado: (2019)

Editorial: The global threat of carbapenem-resistant gram-negative bacteria
por: Dropa, Milena, et al.
Publicado: (2022)

Evaluating the Efficacies of Carbapenem/β-Lactamase Inhibitors Against Carbapenem-Resistant Gram-Negative Bacteria in vitro and in vivo
por: El Hafi, Bassam, et al.
Publicado: (2019)

Long-Term Dominance of Carbapenem-Non-Susceptible Pseudomonas aeruginosa ST111 in Hematologic Malignancy Patients and Hematopoietic Cell Transplant Recipients
por: Zhang, Liyang, et al.
Publicado: (2022)

Safety of a Carbapenem Restriction Policy in Patients with Gram-Negative Bacteremia
por: Mani, Nandita S, et al.
Publicado: (2017)

Risk Factors for Development of Carbapenem Resistance Among Gram-Negative Rods
por: Richter, Stefan E, et al.
Publicado: (2019)

Molecular epidemiology & therapeutic options of carbapenem-resistant Gram-negative bacteria
por: Garg, Atul, et al.
Publicado: (2019)

Attributable burden in patients with carbapenem-nonsusceptible gram-negative respiratory infections
por: Tabak, Ying P., et al.
Publicado: (2020)

The Place of Meropenem–Vaborbactam in the Management of Carbapenem-Resistant Gram-Negative Infections
por: Chopra, Teena
Publicado: (2021)

Emergence of Carbapenem-Resistant Gram-Negative Isolates in Hospital Settings in Djibouti
por: Ragueh, Ayan Ali, et al.
Publicado: (2023)

In Vitro Activity of Essential Oils Against Gram-Positive and Gram-Negative Clinical Isolates, Including Carbapenem-Resistant Enterobacteriaceae
por: Patterson, Jan E, et al.
Publicado: (2019)

Drug Resistance and Molecular Epidemiology of Carbapenem Resistant Gram-negative Bacilli Isolates
por: Naim, Huma, et al.
Publicado: (2018)

Molecular characterization of carbapenem-resistant Gram-negative bacilli clinical isolates in Algeria
por: Bourafa, Nadjette, et al.
Publicado: (2018)

The threat of carbapenem-resistant gram-negative bacteria in a Middle East region
por: Davoudi-Monfared, Effat, et al.
Publicado: (2018)

Isoalantolactone restores the sensitivity of gram‐negative Enterobacteriaceae carrying MCR‐1 to carbapenems
por: Lu, Na, et al.
Publicado: (2020)

Cannot write session to /tmp/vufind_sessions/sess_dnefo1dt2hre6na3s76svvcgk5